• Recently, the QRS duration on 12-lead ECG has been suggested as a risk marker for vulnerability to dangerous arrhythmias. (medscape.com)
  • Men are affected roughly ten times as often as women, and men also display the highest risk of experiencing malign ventricular arrhythmias. (ecgwaves.com)
  • However, the ECG changes in early repolarization are easy to separate from those in Brugada syndrome and the risk of ventricular arrhythmias and sudden cardiac death is considerably lower than the risk among patients with Brugada syndrome. (ecgwaves.com)
  • In some patients, the intravenous administration of drugs that block sodium channels may unmask or modify the ECG pattern, aiding in diagnosis and/or risk stratification in some individuals. (medscape.com)
  • It increases the risk of abnormal heart rhythms and sudden cardiac death. (wikipedia.org)
  • Those at higher risk of sudden cardiac death may be treated using an implantable cardioverter defibrillator (ICD). (wikipedia.org)
  • [ 13 ] Patients should be risk-stratified using the techniques described below, and a decision on implantable cardioverter-defibrillator (ICD) implantation should be made accordingly. (medscape.com)
  • the risk for cardiomyopathy increases as the cumulative dose increases and is also dependent on other/additional risk factors. (medilib.ir)
  • In those without symptoms the risk of death is much lower, and how to treat this group is less clear. (wikipedia.org)
  • Abrupt loss of pre-excitation (short PR/delta wave) on ECG or exercise ECG indicates a lower risk. (escardio.org)
  • The presence of all four risk factors was associated with a 95% probability of needing a pacemaker within 1 year of follow-up. (revespcardiol.org)
  • Prior to upgrading interventions, clinicians need to balance the risks and benefits of transvenous lead extraction (TLE), additional lead implantation or lead abandonment. (bvsalud.org)
  • Brugada syndrome is characterized by cardiac conduction abnormalities (ST segment abnormalities in leads V 1 -V 3 on EKG and a high risk for ventricular arrhythmias) that can result in sudden death. (nih.gov)
  • EKG monitoring every one to two years for at-risk individuals with a family history of Brugada syndrome or who have a known pathogenic variant that can lead to Brugada syndrome. (nih.gov)
  • Backround: Patients with a drug-induced Brugada syndrome (BS) are considered at a lower risk than those with the spontaneous type I pattern. (researchgate.net)
  • Aims: Risk stratification in Brugada Syndrome (BS) remains challenging. (researchgate.net)
  • In some patients, the intravenous administration of drugs that block sodium channels may unmask or modify the ECG pattern, aiding in diagnosis and/or risk stratification in some individuals. (medscape.com)
  • The results of this test support the clinical diagnosis and are important for the early identification of family members at potential risk. (medscape.com)